Ultrasound Guided Botulinum Toxin Type A Injection of Subacromial-Subdeltoid Bursa in Hemiplegic Shoulder Pain

NCT04467450 EARLY_PHASE1 UNKNOWN

Good shoulder function is a prerequisite for effective hand function, as well as for performing multiple tasks involving mobility, ambulation, and activities of daily living (ADL). A common sequela of stroke is hemiplegic shoulder pain, which can hamper functional recovery and subsequently lead to disability. Hemiplegic shoulder pain can begin as early as 2 weeks post stroke but typically occurs within 2-3 months post stroke.

Details

Lead sponsor	Benha University
Phase	EARLY_PHASE1
Status	UNKNOWN
Enrolment	36
Start date	Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Subacromial Bursitis
• Subdeltoid Bursitis

Interventions

• botulinum toxin type A
• Methyl Prednisolonate

Countries

Egypt